Blood pressure and stroke in heart failure in the reasons for geographic and racial differences in stroke (regards) study

Stroke

Volumn 40, Issue 12, 2009, Pages 3706-3710

  Pullicino, Patrick M ^a,b   McClure, Leslie A ^e   Wadley, Virginia G ^c   Ahmed, Ali ^c,f   Howard, Virginia J ^e   Howard, George ^e   Safford, Monika M ^d  

^a UNIVERSITY OF KENT   (United Kingdom)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c Department of Medicine   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain infarction; Cardiac disease; Hypertension

Indexed keywords

DIGOXIN; HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GEOGRAPHIC DISTRIBUTION; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; SMOKING HABIT; SOCIAL STATUS; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; COHORT STUDIES; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DIGOXIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GEOGRAPHY; HEART FAILURE; HUMANS; HYPOTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; STROKE;

EID: 72649088571     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.561670     Document Type: Article

References (34)

1. Han SW, Nam HS, Kim SH, Lee JY, Lee K-Y, Heo JH. Frequency and significance of cardiac sources of embolism in the TOAST classification. Cerebrovasc Dis. 2007;24:463-468.
2. Pullicino P, Homma S, Thompson JL, Freudenberger RS, Sacco RL, Mohr JP. Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm. Cerebrovasc Dis. 2008;26:322-327.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagu-lation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
4. Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA. 1983;250: 2942-2946.
5. Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL. Ischemic stroke after heart failure: a community-based study. Am Heart J. 2006;152:102-109.
6. Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, Brass LM, Frishman W, Price T, Stamler J, Systolic HEP. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Stroke. 1998;29:1333-1340.
7. Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke-the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000;284:465-471.
8. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostine RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D; the Fra-mingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068-3072.
9. Loh E, Sutton MSJ, Wun CCC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moyé LA, Goldhaber SZ, Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251-257.
10. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997;29: 1074-1080.
11. Filippatos GS, Adamopoulos C, Sui X, Love TE, Pullicino PM, Lubsen J, Bakris G, Anker SD, Howard G, Kremastinos DT, Ahmed A. A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure. Am J Cardiol. 2008;101: 1772-1776.
12. Mujib M, Giamouzis G, Agha SA, Aban I, Sathiakumar N, Ekundayo OJ, Zamrini E, Allman RM, Butler J, Ahmed A. Epidemiology of stroke in chronic heart failure patients with normal sinus rhythm: findings from the DIG stroke sub-study. Int J Cardiol. 2009 May 11 [Epub ahead of print].
13. Hays AG, Sacco RL, Rundek T, Sciacca RR, Jin Z, Liu R, Homma S, Di Tullio MR. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke. 2006;37:1715-1719.
14. Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G, Mark DB, Lee KL, Bardy GH; the SCD-HeFT Investigators. Risk factors for thromboembolism in the SCD-Heft Study. Circulation. 2007;115:2637-2641.
15. Zuccala G, Onder G, Pedone C, Carosella L, Pahor M, Bernabei R, Cocchi A; the GIFA (SIGG-ONLUS) investigators. Hypotension and cognitive impairment. Selective association in patients with heart failure. Neurology. 2001;57:1986-1992.
16. Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R. Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry. 1997;63: 509-512.
17. Wadley VG, McClure LA, Howard VJ, Unverzagt FW, Go RC, Moy CS, Crowther MR, Gomez CR, Howard G. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or TIA in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2007;38:1143-1147.
18. Raphael CE, Whinnet ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, Mayet J, Francis DP. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart. 2009;95:56-62.
19. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135-143.
20. Meschia JF, Brott TG, Chukwudelunzu FE, Hardy J, Brown RD Jr, Meissner I, Hall LJ, Atkinson EJ, O'Brien PC. Verifying the stroke-free phenotype by structured telephone interview. Stroke. 2000;31: 1076-1080.
21. Fonseca C, Oliveira AG, Mota T, Matias F, Morais H, Costa C, Ceia F; EPICA Investigators. Evaluation of the performance and concordance of clinical questionnaires for the diagnosis of heart failure in primary care. Eur J Heart Fail. 2004;6:813-820.
22. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke-predictors for death, dependency, and recurrent stroke within the first year. Stroke. 2003;34:122-126.
23. Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A, Lewis CE, Williams OD, Hulley SB. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360: 1179-1190.
24. Georgiadis D, Sievert M, Cencetti S, Uhlmann F, Krivokuca M, Zierz S, Werdan K. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J. 2000;21:407-431.
25. Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH, Hong MK, Song JK, Park SW, Park SJ, Kim JJ. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 2006;97:1365-1369.
26. Ionita C, Bogdanova O, Xavier A, Kirmani J, Qureshi AI, Pullicino P. Cerebral ischemia in patients with left ventricular systolic dysfunction. Eur J Neurol. 2004;11:59.
27. Pullicino P, Mifsud V, Wong E, Graham S, Ali I, Smajlovic D. Hypoperfusion-related cerebral ischemia and cardiac left ventricular systolic dysfunction. J Stroke Cerebrovasc Dis. 2001;10:178-182.
28. Tominaga S, Strangaard S, Uemura K, Ito K, Kutsuzawa T, Lassen NA, Nakamura T. Cerebrovascular CO2 reactivity in normotensive and hypertensive man. Stroke. 1976;7:507-510.
29. Port S, Demer L, Jennrich R, Walter D, Garfinkel A. Systolic blood pressure and mortality. Lancet. 2000;355:175-180.
30. Pullicino P, Thompson JLP, Barton B, Levin B, Graham S, Freudenberger RS; The WARCEF Investigators. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives and design. J Card Fail. 2006;12:39-46.
31. National Heart Lung and Blood Institute. Clinical Advisory on Systolic Blood Pressure. 2000. Available at: www.nhlbi.nih.gov/new/press/ may04-00.htm. Accessed June 7, 2009.
32. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041
33. NHLBI Factbook Fiscal Year 2006. Disease Statistics. 2009. Available at: www nhlbi.gov/about/factbook/toc.htm. Accessed February 11, 2008.
34. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336: 525-533.